# Effect of Nalbuphine and Naloxone on Experimentally Induced Skin Sensitivity

> **NCT00947284** · NA · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 3 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** nalbuphine plus naloxone
- **DRUG:** nalbuphine plus saline
- **DRUG:** naloxone plus saline

## Key facts

- **NCT ID:** NCT00947284
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Experimental pain model didn't work as anticipated.
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947284, "Effect of Nalbuphine and Naloxone on Experimentally Induced Skin Sensitivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*